GALA THERAPEUTICS Trademark

Trademark Overview

On Friday, June 8, 2018, a trademark application was filed for GALA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the GALA THERAPEUTICS trademark a serial number of 87954071. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 24, 2020. This trademark is owned by Gala Therapeutics, Inc.. The GALA THERAPEUTICS trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Consulting services to healthcare and medical services providers in the field of pulmonary diseases, in the nature of lung cancer, chronic obstructive pulmonary disease (COPD), and asthma
gala therapeutics

General Information

Serial Number87954071
Word MarkGALA THERAPEUTICS
Filing DateFriday, June 8, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 24, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 27, 2018

Trademark Statements

Goods and ServicesConsulting services to healthcare and medical services providers in the field of pulmonary diseases, in the nature of lung cancer, chronic obstructive pulmonary disease (COPD), and asthma
Disclaimer with Predetermined Text"THERAPEUTICS"

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, June 14, 2018
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGala Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025
Party NameGala Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10169

Trademark Events

Event DateEvent Description
Monday, August 24, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 24, 2020ABANDONMENT - NO USE STATEMENT FILED
Wednesday, January 8, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 6, 2020SOU EXTENSION 2 GRANTED
Monday, January 6, 2020SOU EXTENSION 2 FILED
Monday, January 6, 2020TEAS EXTENSION RECEIVED
Friday, January 3, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, January 3, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, January 2, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 2, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 7, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 7, 2019CORRECTED NOA E-MAILED
Tuesday, August 6, 2019DIVISIONAL PROCESSING COMPLETE
Friday, July 19, 2019DIVISIONAL REQUEST RECEIVED
Tuesday, August 6, 2019SOU EXTENSION 1 GRANTED
Friday, July 19, 2019SOU EXTENSION 1 FILED
Tuesday, August 6, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, July 19, 2019TEAS REQUEST TO DIVIDE RECEIVED
Friday, July 19, 2019TEAS EXTENSION RECEIVED
Tuesday, January 22, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 27, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 27, 2018PUBLISHED FOR OPPOSITION
Wednesday, November 7, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, October 19, 2018ASSIGNED TO LIE
Monday, October 1, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 1, 2018EXAMINER'S AMENDMENT ENTERED
Monday, October 1, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, October 1, 2018EXAMINERS AMENDMENT E-MAILED
Monday, October 1, 2018EXAMINERS AMENDMENT -WRITTEN
Wednesday, September 26, 2018ASSIGNED TO EXAMINER
Thursday, June 14, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, June 12, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

therapeutics gala pulmonary services chronic cancer obstructive disease asthma copd lung diseases